PPARG and atherosclerosis: In their 2019 study, Wu et al. used these apoptotic cell mimetics to package a PPARγ agonist in an ApoE−/− murine model of atherosclerosis, in which they were able to confirm that the constructs are effectively targeted to macrophages within atherosclerotic plaques (Wu et al., 2019).